Value of Ki67 Proliferation Index in Identifying Patients with High-Risk Breast Cancer

被引：0
|
作者：
Stone, J. [1 ]
Ordobazari, A. [1 ]
Hunt, B. [1 ]
Behmaram, B. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
323
引用
收藏
页码：82A / 83A
页数：2
相关论文
共 50 条
  • [21] Ki67 Index in Breast Cancer: Correlation with Other Prognostic Markers and Potential in Pakistani Patients
    Haroon, Saroona
    Hashmi, Atif Ali
    Khurshid, Amna
    Kanpurwala, Muhammad Adnan
    Mujtuba, Shafaq
    Malik, Babar
    Faridi, Naveen
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4353 - 4358
  • [22] Evaluating Tumor Size to Ki67 Proliferation Index Ratio for Optimizing Surgical Axillary Treatment Decisions in Breast Cancer Patients
    Pellicciaro, Marco
    Materazzo, Marco
    Bertolo, Alice
    Tacconi, Federico
    Bastone, Sebastiano Angelo
    Calicchia, Francesco
    Eskiu, Denisa
    Toscano, Enrica
    Sadri, Amir
    Treglia, Michele
    Berretta, Massimiliano
    Longo, Benedetto
    Cervelli, Valerio
    Buonomo, Oreste Claudio
    Vanni, Gianluca
    CANCERS, 2025, 17 (05)
  • [23] Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
    Jurikova, Miroslava
    Danihel, Ludovit
    Polak, Stefan
    Varga, Ivan
    ACTA HISTOCHEMICA, 2016, 118 (05) : 544 - 552
  • [24] Ki67 proliferative index in patients with early breast cancer and its association with clinicopathological factors
    Damjanovic, D.
    Rajc, J.
    Marinovic, E. Matuzalem
    Dumencic, B.
    Gudelj, R.
    Bakula, M.
    Alaghehbandan, R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S67 - S67
  • [25] Prognostic value of Ki67 labelling index for treatment of invasive breast cancer - restrospective analysis of 3150 women with breast cancer
    Hass, H. G.
    Seywald, M.
    Zabieglinski, T.
    Kunzmann, V.
    Denzlinger, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 86 - +
  • [26] High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE
    Harbeck, Nadia
    Johnston, Stephen
    Fasching, Peter
    Martin, Miguel
    Toi, Masakazu
    Rastogi, Priya
    Song, Chuangui
    Molthrop, David
    Vuky, Jacqueline
    Yamashita, Toshinari
    Jaliffe, Georgina Garnica
    Gumus, Mahmut
    Headley, Desiree
    Wei, Ran
    Barriga, Susana
    Munoz, Maria
    Method, Michael
    Andre, Valerie
    Kreipe, Hans
    O'Shaughnessy, Joyce
    CANCER RESEARCH, 2021, 81 (04)
  • [27] Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index
    Jalava, P
    Kuopio, T
    Juntti-Patinen, L
    Kotkansalo, T
    Kronqvist, P
    Collan, Y
    HISTOPATHOLOGY, 2006, 48 (06) : 674 - 682
  • [28] Ki67 assessment in breast cancer: an update
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    PATHOLOGY, 2017, 49 (02) : 166 - 171
  • [29] Ki67/MIB-1 Proliferation index in meningiomas
    Brodhun, M.
    Thomas, M.
    Lehrmann, K.
    Patt, S.
    HISTOPATHOLOGY, 2008, 53 : 313 - 314
  • [30] The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients
    Golmohammadi, Rahim
    Pejhan, Akbar
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (09) : 871 - 875
12345